Evidence map›Paper›PMID 28069821›Full record

ArticleJournal of bacteriology2017

Characterization of Engineered PreQ1 Riboswitches for Inducible Gene Regulation in Mycobacteria.

Erik R Van Vlack, Shana Topp, Jessica C Seeliger

Abstract read
In one paragraph

Article in Journal of bacteriology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. RNA Triple Helices: From Structures and Mechanisms to Therapeutic Targets.International journal of biological sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Riboswitches, from cognition to transformation.Synthetic and systems biotechnology · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Nucleobase mutants of a bacterial preQThe Journal of biological chemistry · 2020
    Article
  11. RNA Switches for Synthetic Biology.Cold Spring Harbor perspectives in biology · 2019
    Review
  12. Recent advances and future trends of riboswitches: attractive regulatory tools.World journal of microbiology & biotechnology · 2018
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erik R Van VlackDepartment of Chemistry, Stony Brook University, Stony Brook, New York, USA.
Shana ToppDepartment of Chemistry, University of California, Berkeley, California, USA.
Jessica C SeeligerDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA jessica.seeliger@stonybrook.edu.

Funding

SBU Chemistry-Biology Interface Training ProgramT32GM092714 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S, TONGE, PETER J · 2010 to 2019
$1.7M
Inducible Gene Regulation in MycobacteriaR21AI103321 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SEELIGER, JESSICA CHUANG · 2013 to 2014
$391k
NIAID NIH HHS R21 AI103321NIGMS NIH HHS T32 GM092714
6 · The paper itself

Abstract

We report here the behavior of naturally occurring and rationally engineered preQ1 riboswitches and their application to inducible gene regulation in mycobacteria. Because mycobacteria lack preQ1 biosynthetic genes, we hypothesized that preQ1 could be used as an exogenous nonmetabolite ligand to control riboswitches in mycobacteria. Selected naturally occurring preQ1 riboswitches were assayed and successfully drove preQ1-dependent repression of a green fluorescent protein reporter in

Indexed as

Gene Expression Regulation, BacterialPyrimidinonesPyrrolesBacillus subtilisBase SequenceGenetic EngineeringLacticaseibacillus rhamnosusMycobacterium smegmatisNucleoside QRiboswitchThermoanaerobacter7-(aminomethyl)-7-deazaguanineNucleoside QPyrimidinonesPyrrolesRiboswitchinducible gene regulationmycobacteriapreQ1riboswitch

Identifiers

PMID28069821
PMCPMC5331669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.